[CLDX] YoY Quarter Result on 31-Dec-2008 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Mar-2009
Financial Year
2008
Quarter
31-Dec-2008 [#Q4]
Profit Trend
QoQ- 2.65%
YoY- -41.85%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Revenue 2,434 37,721 4,733 2,988 1,720 380 634 25.12%
PBT -12,294 23,046 -13,020 -6,386 -5,254 -6,464 -4,068 20.23%
Tax 268 1,449 -159 -1,444 -314 -252 -508 -
NP -12,732 22,661 -12,943 -7,453 -5,254 -6,212 -3,980 21.37%
Tax Rate - -6.29% - - - - - -
Total Cost 15,166 15,060 17,676 10,442 6,974 6,592 4,614 21.92%
Ratio Analysis
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
NP Margin -523.09 60.08 -273.46 -249.41 -305.49 -1,634.19 -627.41 -2.98%
Per Share
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
EPS -3.81 10.61 -6.13 -7.08 -7.78 -15.04 -9.66 -14.35%
EPS Diluted -3.81 10.61 -6.13 -7.07 -7.78 -14.87 -9.66 -14.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.